Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
Clinical trial NCT02283788 · COMPLETED
Trial details
- NCT number
- NCT02283788
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-06-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.